⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Global Times: A target of seeking progress while maintaining stability, being proactive and pragmatic
prnewswire.com
LUV
XPEV
LI
NIO
PLUG
SEDG
ENPH
DQ
JKS
BE
FCEL
RUN
FSLR
BABA
JD
PDD
BYDDY
TSLA
GM
F
RIVN
LCID
NVDA
AMD
INTC
MU
AMAT
LRCX
KLAC
ASML
SMCI
MSFT
GOOGL
AMZN
IBM
ORCL
CRM
ADBE
PYPL
COIN
UPST
SOFI
AXP
V
MA
GS
JPM
MS
BAC
WFC
CMCSA
VZ
T
NFLX
DIS
CMG
MCD
SBUX
YUM
PEP
KO
PG
JNJ
PFE
MRK
BMY
LLY
ABBV
GILD
AMGN
BIIB
REGN
VRTX
MRNA
BNTX
AZN
NVO
SNY
XOM
CVX
SHEL
BZUN
VIPS
QCOM
MRVL
NXPI
ON
ADI
MCHP
AVGO
QGEN
ILMN
EXAS
MDLZ
KDP
GIS
KHC
CL
EL
NKE
UA
LULU
CPRI
PVH
M
TJX
ROST
BBY
HD
LOW
COST
WMT
TGT
KR
LVS
MGM
WYNN
CCL
RCL
NCLH
DAL
UAL
AAL
BA
GD
LMT
RTX
GE
HON
CAT
DE
MMM
DOW
DD
ECL
IFF
ADM
CF
MOS
NTR
BHP
RIO
VALE
AA
FCX
STLD
NUE
CFG
KEY
USB
PNC
BBT
STI
BBVA
HSBC
SCHW
RJF
SYF
CINF
Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight
prnewswire.com
GSK
UPB
SNY
LLY
AZN
AMGN
REGN
PFE
MRK
TEVA
NVS
INSM
LYRA
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
globenewswire.com
MRK
NTHI
Les réformes réglementaires de l’UE et l’innovation mondiale dans le domaine des soins de santé seront au cœur de la conférence DIA Europe 2026
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
Les réformes réglementaires de l’UE et l’innovation mondiale dans le domaine des soins de santé seront au cœur de la conférence DIA Europe 2026
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
Regulatorische Reformen der EU und globale Innovationen im Gesundheitswesen stehen auf DIA Europe 2026 im Mittelpunkt
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
Regulatorische Reformen der EU und globale Innovationen im Gesundheitswesen stehen auf DIA Europe 2026 im Mittelpunkt
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS
Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc.
prnewswire.com
GILD
PFE
MRK
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
prnewswire.com
MRK
ACLX
LLY
ONCY
GILD
EU Regulatory Reforms and Global Healthcare Innovation to be Focus of DIA Europe 2026
businesswire.com
AMGN
AZN
GSK
MRK
SNY
NVS